Peer Review History
| Original SubmissionOctober 15, 2024 |
|---|
|
Dear Dr. Vianna Gonçalves da Costa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Vincenzo De Luca Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: [This proposal was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brazil (CAPES) – Financing Code 001.]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: No ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for the opportunity to review this scoping review protocol manuscript. This is an interesting topic in the field of patient safety. However, the protocol requires additional revisions. Below are comments for your consideration: 1) Ensure consistency in your writing mechanics – you use past/present/future tense in multiple sections which detracts from your main messages. There are also issues with sentence structure, typos and grammatical issues that should be addressed to improve flow and readability. 2) Abstract - Clarify the abstract. Some sections are unclear. For example, you state “Despite these advances, adverse events victims, including professionals and institutions, to progress beyond the patient.” It is not clear what this sentence is conveying. 3) Introduction - The introduction requires significant revisions as it was difficult to comprehend. Particular attention is needed to improve sentence/paragraph structure, organization and flow. Consider strengthening the background to build the case for why this review is needed and reduce the amount of content dedicated to explaining existing systematic/scoping reviews. The main purpose is to demonstrate that your proposed scoping review is different from what already exists in the literature. 4) Global approach - You note that your scoping review will take a global approach; however, you begin your introduction by referencing the Brazilian National Program for Patient Safety, which is very specific to one country. Consider integrating literature from a global perspective. 5) Methodology- Please provide a rationale for why the scoping review methodology (compared to other literature review methods) is the best choice for answering your questions. 6) Review question - Your review question is: “What does the literature present about the phenomenon of second victim and the repercussions suffered by health professionals involved in incidents related to patient safety in health services”. However, in your review of the literature (on page 7) you note that there are already systematic reviews looking at the impact of adverse events on second victims. Please further clarify how your scoping review will make a different contribution to the literature. 7) Language - You note that you will not limit the language – please indicate how you will review sources that are not in English or in the languages that your team is proficient in. 8) Population/participants – you separate health professionals into two categories – higher education and secondary education. Please clarify this as this conceptualization may be well known across global jurisdictions. One suggestion is to state that you include both regulated and non-regulated health professionals. 9) Line 219 is unclear “the choice of the term “health professionals” instead of “health workers” is based on the definition that a health professional is a person who works in one of the professions related to health sciences, different from health professionals’ health, which includes…”. This sentence seems to be missing something. 10) Line 245 subheading – please clarify what is ‘types of fonts’. You may be referring to ‘types of sources’ 11) You noted that a full search was already completed on June 26th – please provide the full search as an appendix. Further, has this review already started? If the full search was conducted in June 2024, it may be worth updating the search before you commence the review to ensure the most up-to-date literature is included. 12) Sources- Please provide further information about the types of sources. For example, what type of studies (Qualitative, quantitative, mixed methods) will you include? Will you include non-empirical sources? What sources will you retrieve grey literature from? Why? what is your rationale for including such sources? 13) Selection of studies – please clarify if you will be piloting the process of selecting studies to ensure members of your team are clear about the inclusion and exclusion criteria and to determine if refinements are needed. 14) Data extraction – please clarify what you mean by 75% agreement (line 291-292) 15) Expected outcomes – please expand on what you anticipate to find and why. Please also clarify what you mean by “this research can contribute to the mapping of the theoretical framework on the phenomenon… (lines 326-328). Is this an existing framework? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Vianna Gonçalves da Costa, plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Vincenzo De Luca Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Partly ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for revising your manuscript. Title: • Consider revising from ‘who went through the second victim phenomenon’ to ‘who have experienced the second victim phenomenon’ Abstract • You introduce the term second victim phenomenon but don’t define what it is. Defining it can enhance clarity in the abstract. Introduction • Specify what patient safety ‘framework’ entails. Are you referring to the second term victim being introduced in the ‘field’ of patient safety? Or a specific framework? • You cite existing systematic and scoping reviews that relate to the topic. Specifically, you reference one scoping review protocol that aligns with your proposed scoping review but note that you are unable to verify the objectives as the manuscript file is not available. Upon reviewing this registration, the objective is identified under the description section (https://doi.org/10.17605/OSF.IO/5CDMU). As it reads, the objective of this scoping review (“to describe the types of psychological and physical symptoms experienced by healthcare professionals who become second victims after a patient safety incident and its impact on their social and professional lives”) is the same objective you propose in your protocol (“to map and characterize the repercussions experienced by healthcare professionals who have gone through the second victim phenomenon due to patient safety-related incidents in healthcare services”). As a result, your proposed reviews are very similar, except that you are not limiting your search to English-language sources. Consider the value of your review as it may be duplicative. Eligibility Criteria • If the search is global, should the search for theses/dissertations be broader and not limited to the Brazilian Digital Library of Theses and Dissertations? Consider using a database such as Proquest Dissertations and Theses Global. • Exclusion – you indicated “We will also exclude studies incorporated into an evidence synthesis, except in cases where the data presented are not otherwise covered in the synthesis.” This requires further elaboration. What specific process will you implement to operationalize this given that based on your review of existing literature, there is a wide range of evidence syntheses on this topic? How will you manage duplication across evidence syntheses? How will your data extraction and analysis differ based on your inclusion of primary and secondary analysis? • If theses/dissertations are being included, why are undergraduate theses being excluded? • Specify what societies, foundations or networks will you review for gray literature. Being explicit is important for transparency. • Population – “the first group includes nurses, physicians, physical therapists, speech therapists, and others.” Suggest state that these are examples rather than presenting it as a specific list. • There is no mention of date limiters. Will you be reviewing the literature published within a specific time frame? Screening and selection • How many articles or what percent of articles will you use to pilot? Data analysis • It is unclear which variables require a mean and median measure. Expected outcomes • This section is quite vague and can benefit from a more detailed discussion about potential implications/significance by linking it back to the issue The Preferred reporting items for systematic review and meta-analysis protocols checklist is missing. There are outstanding issues that need to be addressed. More importantly, an existing scoping review (based on your review of existing knowledge syntheses and protocols) on the same topic and objective already exists. Unless there is a strong justification for how this review is different than the existing registered scoping protocol in OSF as referenced in the manuscript, this may be duplicative. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Vianna Gonçalves da Costa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Vincenzo De Luca Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: No ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for the opportunity to review the manuscript again. There are still several sections within the manuscript that are unclear which I have identified below. I note that there was no detailed response provided by the authors in response to the previous comments I provided. The response back to the reviewers was generic stating: “We appreciate the contributions to the presentations and understand that they are relevant. After reading the reviewers' responses, the manuscript was revised to meet the reviewers' recommendations. In addition, it underwent major spelling and language revision. Therefore, we hope that the revised manuscript meets the guidelines for publication.” 1. The abstract needs to align with changes in text – based on the revisions, gray literature will also be retrieved from Proquest Dissertations and Theses Global 2. Introduction – “The term second victim is introduced within the patient safety framework and refers to healthcare professionals who experience psychological and professional distress following an adverse patient event” – this was previously raised and it is still not clear what ‘the patient safety framework’ entails. Is this a specific framework or are you speaking in general terms that this has been introduced in the field of patient safety? 3. Eligibility criteria - “Additionally, within gray literature, publications cited in the reference list of the evidence synthesis will be considered if they were published by societies, foundations, or networks addressing the second victim phenomenon” – What does evidence synthesis refer to? 4. Exclusion criteria – “We will exclude abstracts from scientific events, opinion articles, and publications in which the studied population comprises students from either regulated or unregulated professions.” It is not clear why abstracts from scientific events, opinion articles are separated out from publications. 5. Exclusion criteria - Further, in your eligibility criteria, you state: “Given that a scoping review can include all types of literature 26-28, this study will consider primary and secondary studies identified in the databases used in the preliminary search.” Since you state ‘all types of literature’ it is unclear if you are excluding or including other forms of literature beyond empirical studies (e.g. peer-reviewed opinion articles, discussion papers, etc) and gray literature. 6. Exclusion criteria - “Regarding primary sources, we will exclude those incorporated into an evidence synthesis. These publications will be identified in the third stage of the search strategy—while reviewing the reference lists of the studies included in the evidence synthesis.” This is still unclear to me. How will you know which publications are incorporated into evidence synthesis during your initial screening? 7. Search strategy: “To ensure the inclusion of up-to-date evidence, we will perform a final search before presenting the results in the review article. This search will cover the same period and align with the last search described in the protocol. In the second step, an experienced librarian specializing in scoping review search strategies will conduct a comprehensive literature search.” It is unclear why you are conducting a final search and then a comprehensive search. Does the first ‘final search’ pertain to MEDLINE? If MEDLINE is a database that is included in your in search, it should be noted in your abstract as well. 8. Search strategy- In the third step, we will examine the reference lists of the full-text sources selected for inclusion in the review, and publications that meet the inclusion criteria may be included”. Previously you mentioned that you would include a review of publications identified in evidence synthesis but this is not mentioned in your search strategy. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Repercussions suffered by health professionals who have experienced the phenomenon of the second victim due to incidents related to patient safety: a scoping review protocol PONE-D-24-36642R3 Dear Dr. Vianna Gonçalves da Costa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vincenzo De Luca Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for revising your manuscript. You've enhanced clarity and I have some outstanding minor suggestions: Introduction – “In the JBI database, we identified two registries: the first being a protocol and the second an article with the aim of synthesizing the best available evidence to explore the meaning of nurses' experiences as second victims of adverse nursing errors 19-20.” I believe you mean you found two papers, not registries. Eligibility criteria – “Examples of higher education or graduate professionals include nurses, doctors, physical therapists, speech therapists, and nutritionists, among others. Mid-level or non-licensed professionals include nursing technicians, laboratory technicians, and radiology technicians, among others.” Since the review is global, suggest making a minor change as in some countries, laboratory technicians, radiology technicians etc. are licensed professionals. Exclusion criteria: This section is written in the past tense – suggest to ensure consistency throughout your manuscript Expected results – suggest clarifying if you mean ‘causes psychological suffering’ versus ‘causes psychic suffering’ I suggest some additional support to address grammatical issues throughout the manuscript for readability and accuracy. Good luck with your review. Thanks again for the opportunity to provide feedback. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-24-36642R3 PLOS ONE Dear Dr. Vianna Gonçalves da Costa, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vincenzo De Luca Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .